Two independent clinical trials have demonstrated the safety and potential effectiveness of stem cell-based therapies in ...

In a small study, researchers transplanted stem cells into the brains of 12 Parkinson’s patients, stopping progression and bringing about improvement in motor function.

In a first-of-its-kind human trial, researchers transplanted iPS-cell-derived dopaminergic progenitors into patients with ...

The trial builds upon over ten years of collaborative research and paves the way for future multi-centre trials led by ...

Clinical trials show stem cell therapies for Parkinson's disease are safe, potentially offering more effective treatment with ...

In a groundbreaking Phase I/II trial conducted at Kyoto University Hospital, researchers have demonstrated the potential of iPS-cell-derived dopaminergic progenitors in treating Parkinson’s disease.

Stem cell therapies are a safe and effective way of treating Parkinson's disease, according to results of two independent ...

Two early-phase clinical trials demonstrate the safety and potential clinical utility of stem cell therapies to ease motor ...

Focal cortical dysplasia (FCD) type 2 is a congenital malformation of the cerebral cortex that is often associated with ...

Focal cortical dysplasia (FCD) type 2 is a congenital malformation of the cerebral cortex that is often associated with difficult-to-treat epilepsy. In the affected areas, nerve cells and their layer ...

Two independent clinical trials demonstrate the safety of stem cell therapies for Parkinson's disease. The papers, published ...

AXS-12, known as reboxetine back when it was available as an antidepressant in the United States, may decrease cataplexy ...